Diabetes-induced activation of canonical and noncanonical nuclear factor-kappaB pathways in renal cortex

Jonathan M Starkey1, Sigmund J Haidacher, Wanda S LeJeune

  • 1Division of Endocrinology, Department of Internal Medicine, Stark Diabetes Center, 8.138 Medical Research Building, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1060, USA.

Diabetes
|April 29, 2006
PubMed

Insights

Diabetes activates nuclear factor-kappaB (NF-kappaB) in the kidney, involving both canonical and noncanonical pathways. This chronic activation, particularly in tubular cells, suggests a novel mechanism contributing to diabetic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Endocrinology

Background:

  • Diabetes mellitus is associated with kidney complications.
  • Nuclear factor-kappaB (NF-kappaB) activation is implicated in diabetic kidney disease.
  • Mechanisms of NF-kappaB activation in diabetes remain incompletely understood.

Purpose of the Study:

  • To investigate the effects of diabetes on NF-kappaB canonical and noncanonical activation pathways in the renal cortex.
  • To elucidate the specific proteins and cellular locations involved in NF-kappaB activation during diabetes.

Main Methods:

  • Utilized diabetic (db/db) mice model.
  • Analyzed renal cortex protein expression and localization via immunohistochemistry.
  • Assessed protein phosphorylation and nuclear translocation.
  • Quantified NF-kappaB DNA binding activity using electrophoretic mobility shift assay (EMSA).

Main Results:

  • Elevated plasma cytokines during early diabetes normalized, but renal cortex cytokine levels remained high.
  • NF-kappaB noncanonical pathway proteins, including IKK-alpha, NIK, and RelB, were significantly increased in tubular epithelial cells.
  • Despite decreased nuclear content of NF-kappaB proteins, EMSA confirmed increased DNA binding activity in diabetic kidneys.
  • NF-kappaB canonical pathway proteins showed no significant changes in cytosolic content.

Conclusions:

  • Diabetes induces chronic NF-kappaB activation in the renal cortex of db/db mice.
  • A novel diabetes-linked mechanism involving both canonical and noncanonical NF-kappaB pathways is suggested.
  • Specific alterations in noncanonical pathway proteins and their localization highlight a key aspect of diabetic nephropathy.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...